Literature DB >> 28154183

The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways.

Lisa Dwane1, William M Gallagher2, Tríona Ní Chonghaile3, Darran P O'Connor4.   

Abstract

The addition of ubiquitin to a target protein has long been implicated in the process of degradation and is the primary mediator of protein turnover in the cell. Recently, however, many non-proteolytic functions of ubiquitination have emerged as key regulators of cellular homeostasis. In this review, we will describe the various non-traditional functions of ubiquitination, with particular focus on how they can be used as signaling entities in cancer formation and progression. Elaboration of this topic can lead to a better understanding of oncogenic mechanisms, as well as the discovery of novel druggable proteins within the ubiquitin pathway.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cancer; deubiquitination; deubiquitylation (deubiquitination); monoubiquitination; non-degradative pathways; polyubiquitin chain; signal transduction; therapeutic intervention; ubiquitination; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2017        PMID: 28154183      PMCID: PMC5339741          DOI: 10.1074/jbc.R116.755694

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  91 in total

Review 1.  Ubiquitin-mediated proteolysis: biological regulation via destruction.

Authors:  A Ciechanover; A Orian; A L Schwartz
Journal:  Bioessays       Date:  2000-05       Impact factor: 4.345

2.  The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.

Authors:  Sebastian M B Nijman; Tony T Huang; Annette M G Dirac; Thijn R Brummelkamp; Ron M Kerkhoven; Alan D D'Andrea; René Bernards
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

Review 3.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Nat Cell Biol       Date:  2011-09-02       Impact factor: 28.824

4.  Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.

Authors:  Ellen E McCarthy; Julide T Celebi; Richard Baer; Thomas Ludwig
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

5.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

6.  Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains.

Authors:  Abdallah K Al-Hakim; Anna Zagorska; Louise Chapman; Maria Deak; Mark Peggie; Dario R Alessi
Journal:  Biochem J       Date:  2008-04-15       Impact factor: 3.857

7.  High USP22 expression indicates poor prognosis in hepatocellular carcinoma.

Authors:  Bo Tang; Fang Tang; Bo Li; Shengguang Yuan; Qing Xu; Stephen Tomlinson; Junfei Jin; Wei Hu; Songqing He
Journal:  Oncotarget       Date:  2015-05-20

8.  HTLV-1 tax stabilizes MCL-1 via TRAF6-dependent K63-linked polyubiquitination to promote cell survival and transformation.

Authors:  Young Bong Choi; Edward William Harhaj
Journal:  PLoS Pathog       Date:  2014-10-23       Impact factor: 6.823

9.  TRAF2 is an NF-κB-activating oncogene in epithelial cancers.

Authors:  R R Shen; A Y Zhou; E Kim; J T O'Connell; D Hagerstrand; R Beroukhim; W C Hahn
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

10.  Novel Lys63-linked ubiquitination of IKKβ induces STAT3 signaling.

Authors:  Leandro H Gallo; April N Meyer; Khatereh Motamedchaboki; Katelyn N Nelson; Martin Haas; Daniel J Donoghue
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more
  27 in total

1.  Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma.

Authors:  Junling Zhuang; Fazal Shirazi; Ram Kumar Singh; Isere Kuiatse; Hua Wang; Hans C Lee; Zuzana Berkova; Allison Berger; Marc Hyer; Nibedita Chattopadhyay; Sakeena Syed; Judy Qiuju Shi; Jie Yu; Vaishali Shinde; Stephen Tirrell; Richard Julian Jones; Zhiqiang Wang; R Eric Davis; Robert Z Orlowski
Journal:  Blood       Date:  2019-02-08       Impact factor: 22.113

Review 2.  The ubiquitin system affects agronomic plant traits.

Authors:  Katrina J Linden; Judy Callis
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

Review 3.  Epigenetic drug discovery: a success story for cofactor interference.

Authors:  A Ganesan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

Review 4.  Emerging Role of Ubiquitin-Specific Protease 19 in Oncogenesis and Cancer Development.

Authors:  Fabiana Alejandra Rossi; Mario Rossi
Journal:  Front Cell Dev Biol       Date:  2022-05-12

Review 5.  Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair.

Authors:  Ksenia G Kolobynina; Alexander Rapp; M Cristina Cardoso
Journal:  Front Cell Dev Biol       Date:  2022-07-05

Review 6.  Ubiquitin-proteasome signaling in lung injury.

Authors:  Natalia D Magnani; Laura A Dada; Jacob I Sznajder
Journal:  Transl Res       Date:  2018-04-23       Impact factor: 7.012

Review 7.  Spectrin and its interacting partners in nuclear structure and function.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2018-03

Review 8.  The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers.

Authors:  Zbyslaw Sondka; Sally Bamford; Charlotte G Cole; Sari A Ward; Ian Dunham; Simon A Forbes
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

9.  Recombinant HCV NS3 and NS5B enzymes exhibit multiple posttranslational modifications for potential regulation.

Authors:  Sergio Hernández; Ariel Díaz; Alejandra Loyola; Rodrigo A Villanueva
Journal:  Virus Genes       Date:  2019-01-29       Impact factor: 2.332

10.  A novel SHARPIN-PRMT5-H3R2me1 axis is essential for lung cancer cell invasion.

Authors:  Tingxiong Fu; Xiuwei Lv; Qingzhi Kong; Changjing Yuan
Journal:  Oncotarget       Date:  2017-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.